Karl‐martin Koch
#154,149
Most Influential Person Now
Karl‐martin Koch's AcademicInfluence.com Rankings
Karl‐martin Kochcomputer-science Degrees
Computer Science
#8338
World Rank
#8765
Historical Rank
Computer Graphics
#166
World Rank
#171
Historical Rank
Karl‐martin Kochphilosophy Degrees
Philosophy
#8659
World Rank
#12076
Historical Rank
Logic
#5684
World Rank
#7101
Historical Rank
Download Badge
Computer Science Philosophy
Why Is Karl‐martin Koch Influential?
(Suggest an Edit or Addition)Karl‐martin Koch's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. (2001) (698)
- Replacement of renal function by dialysis (1979) (466)
- Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. (1999) (380)
- Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. (1996) (280)
- Hemodialysis Hypotension: The Interleukin Hypothesis (1983) (250)
- Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. (1998) (245)
- Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. (1979) (220)
- Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. (1990) (209)
- Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. (1997) (196)
- Dialysis-related amyloidosis. (1992) (195)
- Differences in the synthesis and kinetics of release of interleukin 1α, interleukin 1β and tumor necrosis factor from human mononuclear cells (1989) (162)
- Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. (1995) (157)
- Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. (1998) (151)
- Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria (1992) (146)
- Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. (1988) (145)
- ENHANCEMENT OF IN-VITRO HUMAN INTERLEUKIN-1 PRODUCTION BY SODIUM ACETATE (1987) (139)
- Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. (2001) (133)
- β2-microglobulin associated amyloidosis: A vanishing complication of long-term hemodialysis? (1997) (131)
- Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells (1999) (131)
- Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. (1997) (130)
- Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells. (1995) (119)
- Gene expression of interleukin-1β during hemodialysis (1993) (115)
- Chronic Induction of C-Reactive Protein by Hemodialysis, but Not by Peritoneal Dialysis Therapy (1996) (114)
- Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. (2000) (109)
- Activated complement C3: a potentially novel predictor of progressive IgA nephropathy. (1997) (109)
- Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy. (1982) (108)
- Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection (1997) (107)
- Effect of acute hypertension on sodium reabsorption by the proximal tubule. (1968) (107)
- Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. (1995) (103)
- Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506 (1998) (101)
- Human interleukin-1 production during hemodialysis. (1986) (99)
- Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss. (1997) (98)
- Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy? (1998) (96)
- Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. (1996) (88)
- Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranes. (1988) (88)
- Deposition of an amyloid-like substance as a possible complication of regular dialysis treatment. (1983) (87)
- Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction? (1995) (87)
- Induction of tumor necrosis factor during extracorporeal blood purification. (1987) (87)
- Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. (1997) (85)
- Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1. (1988) (84)
- Clearance and synthesis rates of beta 2-microglobulin in patients undergoing hemodialysis and in normal subjects. (1991) (83)
- Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes. (1987) (83)
- Risk of renal cell carcinoma after kidney transplantation. (1997) (79)
- Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. (1995) (79)
- Interleukin-1 and its relevance in patients treated with hemodialysis. (1988) (77)
- The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. (1994) (77)
- Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. (1995) (72)
- β2-Microglobulin Kinetics During Haemodialysis and Haemofiltration (1987) (70)
- Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial. (1994) (69)
- Tumor necrosis factor-α during continuous high-flux hemodialysis in sepsis with acute renal failure (1999) (69)
- Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis. (1998) (68)
- Pathogenesis of sclerosing peritonitis in CAPD. (1984) (64)
- Colour doppler ultrasound assessment of arteriovenous haemodialysis fistulas (1992) (64)
- The long-term course of hepatitis C after kidney transplantation. (1996) (63)
- Beta(2)-microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyzer membrane. (2002) (62)
- Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood. (1996) (61)
- Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients. (1997) (60)
- Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia. (1983) (59)
- Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenation. (1988) (59)
- Anemia of the regular hemodialysis patient and its treatment. (1974) (59)
- Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin. (1990) (58)
- Improving anemia by hemodialysis: effect of serum erythropoietin. (1980) (58)
- Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria. (1997) (56)
- Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. (1997) (56)
- Erythropoietin: Molecular Physiology and Clinical Applications (1993) (56)
- Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study. (1991) (55)
- Plasma noradrenaline levels in regular haemodialysis patients. (1976) (54)
- Hemodialysis-related induction of beta-2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes. (1989) (54)
- C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. (1998) (50)
- Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis. (1998) (50)
- Cyclophosphamide pulse therapy in Wegener's granulomatosis. (1991) (50)
- Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis. (2002) (50)
- Increase of C-reactive protein serum values following haemodialysis. (1990) (49)
- Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects. (1996) (49)
- Antioxidant‐oxidant balance in the glomerulus and proximal tubule of the rat kidney (1998) (49)
- Kidney transplantation in Alport's syndrome: long-term outcome and allograft anti-GBM nephritis. (1992) (48)
- [Skin changes in long-term dialysis patients. clinical study]. (1982) (48)
- Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria. (1992) (47)
- Testosterone Therapy for Anaemia in Maintenance Dialysis (1971) (47)
- Endogenous fibroblast growth factor-2 mediates cytotoxicity in experimental mesangioproliferative glomerulonephritis. (1998) (46)
- Cyclosporine-associated posttransplant hypertension incidence and effect on renal transplant function. (1988) (46)
- Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients. (1994) (46)
- Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis? (1997) (44)
- Clinical experience with home automated peritoneal dialysis. (1994) (43)
- Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety. (1997) (42)
- Differing haemodynamic stability due to differing sympathetic response: comparison of ultrafiltration, haemodialysis and haemofiltration. (1980) (41)
- Dialysis related amyloidosis: a disease of chronic retention and inflammation? (1992) (41)
- Effect of changes in renal perfusion pressure on the suppression of proximal tubular sodium reabsorption due to saline loading. (1969) (37)
- Cyclosporin A inhibits PGE2 release from vascular smooth muscle cells. (1987) (36)
- Variations of recombinant human erythropoietin application in hemodialysis patients. (1990) (33)
- Complement Activation during Hemodialysis (1985) (33)
- How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation. (1996) (32)
- Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid. (1998) (32)
- Gene expression of interleukin-1 beta during hemodialysis. (1993) (32)
- Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy: a case report and review of the literature. (1993) (31)
- High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation (1996) (31)
- Specific imaging of dialysis-related amyloid deposits using 131I-beta-2-microglobulin. (1989) (31)
- Transfer of endogenous pyrogens across artificial membranes? (1998) (31)
- Reduced gonadal toxicity after i.v. cyclophosphamide administration in patients with nonmalignant diseases. (1998) (30)
- The Role of Formaldehyde in the Formation of Haemodialysis‐Associated Anti‐N‐Like Antibodies 1 (1978) (30)
- The use of epoetin beta in anemic predialysis patients with chronic renal failure. (1995) (30)
- The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes. (1995) (30)
- β2-Microglobulin Kinetics During Haemofiltration (1988) (29)
- Recurrence of membranoproliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C. (1996) (29)
- Subcutaneous amyloid-tumor of beta-2-microglobulin origin in a long-term hemodialysis patient. (1989) (29)
- Hemodynamics in hemofiltration. (1983) (28)
- Calcium Channel Blockers for Kidney Protection (1990) (27)
- Survival and adequacy in long-term hemodialysis. (1991) (27)
- Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. (1999) (27)
- Interstitial nephritis associated with 5-aminosalicylic acid. (1994) (26)
- Subcutaneous erythropoietin: a comparison of daily and thrice weekly administration. (1991) (26)
- New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients. (1996) (26)
- Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia. (1988) (25)
- Urinary IgA, secretory IgA and secretory component in women with recurrent urinary tract infections. (1990) (25)
- CAPD is a second-class treatment. (1985) (25)
- LTB4 in nephrotoxic serum nephritis in rats. (1989) (25)
- Hemolysis and anemia in anti-N-like antibody positive hemodialysis patients. (1978) (25)
- β2-MICROGLOBULIN AND HAEMODIALYSIS (1987) (25)
- Tumour-like growth of parathyroid autografts in uraemic patients. (1981) (24)
- Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes. (1985) (23)
- Effects of Recombinant Human Erythropoietin Treatment in End-Stage Renal Failure Patients (1989) (23)
- Role of xanthine oxidase in passive Heymann nephritis in rats. (1999) (23)
- Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis (1994) (23)
- Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats (1997) (23)
- Quality of water and dialysate in haemodialysis. (1996) (23)
- Impaired endotoxin-induced interleukin-1 beta secretion, not total production, of mononuclear cells from ESRD patients. (1995) (23)
- Removal of Circulating Cytokines by Hemodialysis Membranes In Vitro (1993) (23)
- Occult blood loss and iron balance in chronic renal failure. (1976) (22)
- An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A. (1989) (22)
- Factors predisposing to priapism in haemodialysis patients. (1976) (22)
- Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system. (1995) (22)
- Serum erythropoietin concentration in anephric patients. (1978) (22)
- Long-term effects of treatment with recombinant human erythropoietin on haemodynamics and tissue oxygenation in patients with renal anaemia. (1990) (22)
- Comparison of haemodialysis (HD) and post dilution haemofiltration (HF) on an unselected dialysis population. (1978) (21)
- Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody-associated vasculitis. (1997) (20)
- Comparative study of C5a plasma levels with different hemodialysis membranes using an enzyme-linked immunosorbent assay. (1989) (20)
- The use of testosterone in bilateral nephrectomized dialysis patients. (1971) (20)
- Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study. (2008) (19)
- The Influence of Vascular Access Modes on the Efficiency of CAVH (1985) (19)
- Hypertension as a possible complication of recombinant human erythropoietin therapy. (1991) (19)
- Is the rise in plasma beta-2-microglobulin seen during hemodialysis meaningful? (1989) (18)
- Recombinant versus natural human 111In-β2-microglobulin for scintigraphic detection of Aβ2m amyloid in dialysis patients (2000) (18)
- Treatment of hyperlipidemia in nephrotic syndrome: time for a change? (1992) (18)
- A specific immunohaemolytic anaemia induced by formaldehyde sterilisation of dialysers. (1983) (18)
- Pathogenetic and diagnostic aspects of dialysis-related amyloidosis. (1995) (17)
- Parathyroid autografts—morphology and function: Six years' experience with parathyroid autotransplantation in uremic patients (1984) (17)
- Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes. (1994) (17)
- Serum erythropoietin measurements using the fetal mouse liver cell culture: the importance of reduction of variation in the specific activity of radioiron--transferrin. (1978) (17)
- Low-dose prednisolone/chlorambucil therapy in patients with severe membranous glomerulonephritis (1994) (16)
- Biological consequences of monocyte activation during hemodialysis. (1987) (16)
- Effect of cyclosporin on kidney proteolytic enzymes in men and rats. (1994) (16)
- Relationship between human leukocyte antigen determinants and courses of hepatitis B virus infection in Caucasian patients with end-stage renal disease. (1996) (16)
- Imaging Techniques in the Diagnosis of Dialysis‐Related Amyloidosis (2001) (16)
- Amyloidosis and its relationship to different dialysers. (1994) (15)
- Gastrointestinal blood loss in haemodialysis patients during use of a low-molecular-weight heparinoid anticoagulant. (1988) (15)
- Efficacy of ultra-pure dialysate in the therapy and prevention of haemodialysis-associated amyloidosis. (2001) (15)
- Cytokine relevance in biocompatibility. (1988) (14)
- No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease. (2008) (14)
- Right ventricular cardiac failure and pulmonary hypertension in a long-term dialysis patient--unusual presentation of visceral beta 2-microglobulin amyloidosis. (1995) (14)
- Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: single-center experience in 40 patients. (1999) (14)
- Hazards of CAPD: Interleukin-1 Production (1986) (13)
- Effect of secondary hyperparathyroidism on the anaemia of end-stage renal failure: in vivo and in vitro studies. (1983) (13)
- Continuous arteriovenous hemofiltration: in vivo functional characteristics and its dependence on vascular access and filter design. (1990) (12)
- Eosinophilia in hemodialysis. (1983) (12)
- Interleukin-1 activation and acute phase response during hemodialysis. (1988) (12)
- [Some topical problems of subtotal parathyroidectomy in patients on haemodialysis]. (1973) (12)
- Scintigraphic methods to detect β2‐microglobulin associated amyloidosis (Aβ2‐microglobulin amyloidosis) (2001) (12)
- Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration. (2001) (12)
- Skin microcirculation and regional peripheral resistance in patients with chronic renal anaemia treated with recombinant human erythropoietin (1990) (12)
- Hemodialysis / hemofiltration: A report of a controlled cross-over study (1980) (12)
- Polyamide--the evolution of a synthetic membrane for renal therapy. (1991) (12)
- Of sodium, symptomatology and syllogism (1983) (12)
- Interleukin-1β Stimulates Glucose Uptake of Human Peritoneal Mesothelial Cells In Vitro (1996) (12)
- On the specificity of assays to detect circulating immunoglobulin A-fibronectin complexes: implications for the study of serologic phenomena in patients with immunoglobulin A nephropathy. (1994) (11)
- Role of excretory graft function for erythropoietin formation after renal transplantation (1990) (11)
- Complications of hemofiltration. (1983) (11)
- Acute and chronic studies of the relationship between sodium flux in hemodialysis and hemofiltration. (1983) (10)
- Role of excretory graft function for erythropoietin formation after renal transplantation (1990) (10)
- Hepatitis-C virus (HCV) in peritoneal dialysis. (1994) (10)
- Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis). (2001) (10)
- Absolute and relative erythropoietin deficiency in renal anemia. (1978) (9)
- Fever and shock during haemofiltration. (1983) (9)
- Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes. (1989) (9)
- Dialysis-associated amyloidosis and beta-2-microglobulin. (1988) (9)
- Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study. (1989) (9)
- Lack of clinical evidence for a specific HIV-associated glomerulopathy in 203 patients with HIV infection. (1992) (9)
- Long-term performance of hemofilters in continuous hemofiltration. (1996) (8)
- Baroreflex in patients undergoing hemodialysis and hemofiltration. (1984) (8)
- Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency (2004) (8)
- Long-term experience with extracorporeal low-density lipoprotein cholesterol removal by dextran sulfate cellulose adsorption (1992) (8)
- Outcome of kidney transplantation in patients with systemic autoimmune diseases. (1997) (8)
- Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane? (1988) (8)
- The variable role of erythropoietin deficiency in the pathogenesis of dialysis anaemia. (1977) (8)
- Exhaled nitric oxide in patients with Wegener's granulomatosis. (1999) (7)
- Dialysis and transplantation. (1993) (7)
- Lethal relapse of Wegener's disease 4 years after successful kidney transplantation. (1995) (7)
- Present status of kidney transplantation. (1992) (7)
- Treatment of renal anemia, 1960-1990. (1991) (7)
- [Autonomic circulatory regulation in uremia (author's transl)]. (1980) (7)
- Retention of cytokine-inducing substances inside high-flux dialyzers. (1996) (6)
- Life-Threatening Complications of Extracorporeal Treatment in Patients with Severe Eosinophilia (2005) (6)
- Haemolysis due to formaldehyde-induced anti-N-like antibodies in haemodialysis patients (1979) (6)
- Is renal involvement a prognostic parameter in patients with infective endocarditis? (1984) (6)
- correction: Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells (2000) (6)
- Beta 2-microglobulin kinetics during haemodialysis and haemofiltration. (1987) (6)
- Renal elimination of beta-2-microglobulin and myoglobin in patients with normal and impaired renal function. (1990) (6)
- Deposition of Nonamyloid Material in Connective Tissue in Uraemia (1984) (5)
- Recombinant versus natural human 111In-beta2-microglobulin for scintigraphic detection of Abeta2m amyloid in dialysis patients. (2000) (5)
- Biocompatibility in hemodialysis: clinical relevance in 1995. (1995) (5)
- [Transplantation hyperparathyroidism--tumorlike growth and autonomous function of autografts of the hyperplastic parathyroid (author's transl)]. (1982) (5)
- Therapy and monitoring of hypersiderosis in chronic renal insufficiency. (1984) (5)
- Renal effects of atrial natriuretic peptide in cirrhotic rats with and without captopril pretreatment. (1993) (5)
- Total parathyroidectomy with autograft of parathyroid tissue in treatment of secondary hyperparathyroidism. (1978) (5)
- Disseminated tuberculosis after renal transplantation (1990) (5)
- Dialysis‐related amyloidosis: Pathogenetic aspects and therapeutic considerations (1996) (5)
- Interleukin-1 and dialysis. (1988) (5)
- Beta 2-microglobulin amyloidosis: why and how to look for it. (1995) (5)
- [Lumbar spondylodiscitis caused by Salmonella enteritidis]. (1994) (5)
- Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients. (1998) (5)
- Persistent Nephrotic Syndrome, High Cholesterol and Mortality (1994) (4)
- Successful therapy of chronic renal allograft failure by enhanced immunosuppression. (1998) (4)
- Effect of low-molecular-weight dextran on proteolytic and nonproteolytic lysosomal enzymes in isolated segments of rat proximal tubule. (1993) (4)
- Interleukin-1 stimulation in the ESRD patient: potential long-term consequences. (1987) (4)
- Beta 2-microglobulin kinetics during haemofiltration. (1988) (4)
- Minimal change nephrotic syndrome in a 74-year-old patient following parenteral administration of sheep cells. (1998) (4)
- [The treatment of renal anemia]. (1989) (4)
- Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients. (1997) (4)
- [Cyclophosphamide bolus therapy in lupus nephritis--status of the clinical study]. (1993) (4)
- Prevention of glomerular hypertrophy and glomerulosclerosis in Milan normotensive rats by low-protein diet, but not by low-dose captopril treatment. (1995) (4)
- Hemofiltration and vascular stability. (1982) (4)
- [Hemodialysis therapy of biguanide-induced lactate acidosis]. (1977) (4)
- Cationic dextran induces mesangioproliferative nephritis in rats independent of glomerular IgA deposition. (1997) (4)
- FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. (1996) (3)
- High output cardiac failure in rats. (1980) (3)
- Hydrophilic high flux polyamide membranes for beta-2-microglobulin removal. (1987) (3)
- Dialyzer repair: a disastrous exercise in cost effectiveness. (2002) (3)
- Diagnostic aspects of β2-microglobulin amyloidosis (1996) (3)
- Clinical aspects of dialysis-related amyloidosis. (1995) (3)
- Are standards and checklists needed in uremia therapy? (1985) (3)
- Adverse cardiovascular effects of partial correction of renal anemia by recombinant human erythropoietin. (1990) (3)
- Bacterial challenge of NISSHO ultrafilter ETF 609: results of in vitro testing. (1996) (3)
- Cardiovascular stability in hemodialysis and hemofiltration (1987) (3)
- [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites]. (1989) (3)
- Diagnostic aspects of beta 2-microglobulin amyloidosis. (1996) (3)
- Disseminated tuberculosis after renal transplantation: A report of two cases (1990) (2)
- Quantification of human urinary free secretory component, secretory and nonsecretory IgA by ELISA. (1989) (2)
- Dialysis and tranplantation: Editorial overview (1992) (2)
- Interleukin-1 and biocompatibility in haemodialysis. (1988) (2)
- [Morphological aspects of parathyroid gland transplantation. Contribution on the clinical relevance of induced, invasive tissue growth]. (1978) (2)
- Plasma Renin Activity and Renal Function in Liver Cirrhosis Before and After Liver Transplantation (1986) (2)
- Glomerular hemodynamics of the clipped kidney: effects of captopril and diltiazem. (1992) (2)
- [Cyclophosphamide pulse therapy of systemic lupus erythematosus with renal involvement]. (1991) (2)
- Does Exogenous Erythropoietin Down-Regulate Endogenous Erythropoietin? (1991) (2)
- Blood-dialyzer interactions: their role in long-term complications of hemodialysis. (1992) (2)
- Treatment of renal anemia with recombinant human erythropoietin (1988) (2)
- International Workshop on Hemofiltration (1983) (1)
- Professor Stanley Shaldon—Honorary member of ERA–EDTA (1994) (1)
- [Haemodialysis in the treatment of biguanide-induced lactate acidosis (author's transl)]. (1978) (1)
- Organ and Metabolic Complications: β2-Microglobulin Amyloidosis (1996) (1)
- From the Prague Spring to a chair in nephrology in Germany: Jan Brod (1912-1985). (2004) (1)
- AB-Amyloidosis and Monokines (1991) (1)
- [Cyclophosphamide bolus therapy in lupus nephritis]. (1993) (1)
- Immune Response to Reuse: Anti-N-Like Antibodies (1986) (1)
- Hemofiltration, future aspects in relation to other treatment modalities of uremia. (1982) (1)
- Dialysis and transplantation. (1992) (1)
- Biological reactions within the extracorporeal blood circuit during hemodialysis. Dialysis Workshop. Tegernsee, March 13-15, 1986. Proceedings. (1987) (1)
- [Syndrome of glomerulonephritis and lung hemorrhages in pediatrics]. (1976) (1)
- Does hemodialysis induce muscular release of myoglobin? (1988) (1)
- Honorary Membership of the Gesellschaft für Nephrology to Prof. Dr. med. et Dr. iur. h.c. Fritz Scheler (1999) (1)
- Beta-2-microglobulin and dialysis-related amyloidosis. Recent developments. (1989) (1)
- [Recurrent hyperparathyroidism following subtotal parathyroidectomy]. (1978) (1)
- [The evaluation of serum ferritin as a measure for the body iron store in comparison with other methods]. (1977) (1)
- International Workshop on Hemofiltration (1983) (1)
- Hemodynamics in hemofiltration. (1982) (1)
- degree of anemia and excretory renal function Serum erythropoietin concentration in chronic renal failure: relationship to (2011) (1)
- [Arterial vascular diseases in chronic hemodialysis patients. Clinical picture and pathogenetic viewpoints]. (1976) (1)
- The interleukin hypothesis (1988) (1)
- Glomerular barrier function for serum proteins in experimental heart failure. (1990) (1)
- Interleukin-1β Stimulates Glucose Uptake of Human Peritoneal Mesothelial Cells in Vitro (1996) (0)
- [Therapy of severe systemic lupus erythematosus]. (1991) (0)
- Subject Index, Vol. 31, 1982 (1982) (0)
- [Iron metabolism in terminal kidney insufficiency]. (1982) (0)
- [Studies on potassium distribution and determination of total body potassium by measurement of K40]. (1965) (0)
- [Clinical picture and therapy of malignant hypertension]. (1975) (0)
- [Primary and secondary microangiopathic hemolytic anemia. An alternative to: thrombotic thrompocytopenic purpura (TTP)--hemolytic-uremic syndrome (HUS)]. (1975) (0)
- Blood Pressure Control by Measurement of Micro-Albuminuria versus Ambulatory 24-Hour Blood Pressure Monitoring (1998) (0)
- My best wishes for the future of Clinical Nephrology ! (2009) (0)
- [Clinical experiences with nocturnal intermittent peritoneal dialysis]. (1993) (0)
- Contents, Vol. 31, 1982 (1982) (0)
- [Drug treatment of chronic glomerulonephritis: pro]. (1985) (0)
- [Serum gastrin level and gastric juice secretion in chronic hemodialysis patients and its effect on them by changing ionized serum calcium]. (1974) (0)
- [Serum gastrin level and gastric juice secretion in chronic hemodialysis patients and their modifications through changes in ionized serum calcium achieved by dialysis or parathyroidectomy]. (1974) (0)
- [Serum erythropoietin concentration before and after partial correction of renal anemia]. (1978) (0)
- [Nephrology. Advances and economic restraints]. (1999) (0)
- P667 – HLA status and hepatitis C virus (HCV) infection in caucasians with end-stage renal disease (ESRD) (1996) (0)
- Erratum: Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells (Nature (1999) 398: (341-344)) (2000) (0)
- [Renal glycosuriae. Diagnosis and therapy]. (1970) (0)
- Subject Index, Vol. 67, 1994 (1994) (0)
- [Erythropoietin and hypertension]. (1988) (0)
- In memoriam: Reinhold Kluthe (2007) (0)
- [Effect of hemodialysis on intestinal iron absorption in chronic kidney insufficiency]. (1974) (0)
- Quality care for haemodialysis patients, 11-13 May, 1995, Wiesbaden, Germany (1996) (0)
- Clinical relevance of biocompatibility. (1994) (0)
- in Experimental Mesangioproliferative Glomerulonephritis (1998) (0)
- [Skeletal histology in uremic osteodystrophy following increase of dialysate calcium concentration to 3,75 mval-1 (preliminary report)]. (1973) (0)
- Performance and biocompatibility of the FD 100 Gambrane hollow-fiber dialyzer. (1986) (0)
- Nephrotoxicity of contrast media Intravenous CT-angiography vs intraarterial digital subtraction angiography in renal artery stenosis (1995) (0)
- Prospects of hemofiltration. (1983) (0)
- Subject Index Vol. 22, 1999 (1999) (0)
- Contents Vol. 22, 1999 (1999) (0)
- Subject Index Vol. 50, 1988 (1988) (0)
- [Primary malignant nephrosclerosis: etiology, morphology, course]. (1977) (0)
- Diabetes and the kidney (1989) (0)
- Contents, Vol. 55, 1990 (1990) (0)
- and matrix production in vivo (1997) (0)
- Treatment of Severe Hypercholesterolemia by Extracorporeal Apheresis: A Comparison between Dextran Sulfate Adsorption and Heparin-induced LDL Precipitation (1992) (0)
- [Role of erythropoietin deficiency in the pathogenesis of renal anemia]. (1979) (0)
- [Goodpasture syndrome: comparison of the disease course under initially massive immunosuppression with and without bilateral nephrectomy]. (1977) (0)
- [Progress in transplantation medicine]. (1996) (0)
- [Long-term management of dialysis patients. II. Beta 2-microglobulin associated amyloidosis and acquired cystic kidney disease]. (1999) (0)
- Title Page / Contents / Introduction (1983) (0)
- NON-INVASIVE IN VIVO DETECTION OF AB-AMYLOIDOSIS USING ITS RADIOLABELLED PRECURSOR PROTEIN* (1991) (0)
- [Long-term management of dialysis patients. I. Hypertension and anemia]. (1999) (0)
- Anewcellularmechanism forcoupling inputsarriving at different cortical layers (1999) (0)
- [Clinical picture and epidemiology of serum hepatitis at the chronic hemodialysis department of the Frankfurt a.M. University]. (1971) (0)
- Complications of hemofiltration. (1982) (0)
- [Autologous epithelial body transplantation in the surgical treatment of secondary azotemic hyperparathyroidism]. (1977) (0)
- P663 - Relationship between HLA status and hepatitis B virus (HBV) infection in caucasians (1996) (0)
- [Effect of testosterone on erythropoiesis in chronic hemodialysis patients]. (1971) (0)
- Treatment of Renal Anemia: Mini-Symposium on Recombinant Human Erythropoietin 7th Annual Meeting of the International Society of Blood Purification, Montpellier, September 1989 (1991) (0)
- Longterm Benefit of Additional Azathioprine in Cyclosporin/Prednisolone-Treated Patients with Chronic Renal Allograft Dysfunction (1997) (0)
- Understanding the epidemic of deaths associated with the use of the Althane dialyzer. (2002) (0)
- Subject Index, Vol. 55, 1990 (1990) (0)
- Sustained negative feedback between haematocrit and serum erythropoietin concentration in end-stage renal failure. (1978) (0)
- [Conservative and surgical therapy of Goodpasture's syndrome]. (1973) (0)
- Hydrophobic PF5070: dialysis repair and sudden death in dialysis patients. (2003) (0)
- Concluding Remarks / Subject Index (1988) (0)
- Biocompatibility in hemodialysis. Workshop on biocompatibility in hemodialysis, Bernried, March 18-20, 1982. (1983) (0)
- Hematologic Disorders in Renal Failure (1998) (0)
- Panel discussion : cardiovascular problems in eng-stage renal therapy (1990) (0)
- Influence of antihypertensive therapy on renal function (2004) (0)
- Potential role of lysosomal proteases in gentamicin nephrotoxicity. (1988) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Karl‐martin Koch?
Karl‐martin Koch is affiliated with the following schools:
